Trial Profile
A phase I study of oral palifosfamide tris in advanced, refractory, solid tumors
Status:
Suspended
Phase of Trial:
Phase I
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Palifosfamide (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Alaunos Therapeutics
- 12 Mar 2008 New trial record.